Quick Answer
Kraig Biocraft Laboratories, Inc. reported Stockholders Equity of -$8.00 million for fiscal year 2025.
Kraig Biocraft Laboratories, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$8.00M | +1.8% |
| 2024 | -$8.15M | -42.8% |
| 2023 | -$5.71M | -62.0% |
| 2022 | -$3.52M | +33.5% |
| 2021 | -$5.30M | +19.4% |
| 2020 | -$6.57M | -22.0% |
| 2019 | -$5.39M | -20.8% |
| 2018 | -$4.46M | -32.1% |
| 2017 | -$3.38M | -43.0% |
| 2016 | -$2.36M | -24.5% |
| 2015 | -$1.90M | -54.8% |
| 2014 | -$1.23M | -2.0% |
| 2013 | -$1.20M | -5.9% |
| 2012 | -$1.13M | -25.1% |
| 2011 | -$906.5K | -46.4% |
| 2010 | -$619.2K | +80.5% |
| 2009 | -$3.17M | -67.2% |
| 2008 | -$1.90M | -942.5% |
| 2007 | -$182.2K | +29.3% |
| 2006 | -$257.7K | — |
| 2006 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.96M | -8.1% | +6.1% |
| June 30, 2025 | -$8.47M | -21.5% | +0.0% |
| March 31, 2025 | -$8.47M | -35.7% | -4.0% |
| December 31, 2024 | -$8.15M | -42.8% | -10.8% |
| September 30, 2024 | -$7.36M | -47.2% | -5.5% |
| June 30, 2024 | -$6.97M | -54.6% | -11.7% |
| March 31, 2024 | -$6.24M | -54.6% | -9.4% |
| December 31, 2023 | -$5.71M | -62.0% | -14.2% |
- Kraig Biocraft Laboratories, Inc. showed an increase of +1.8% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Kraig Biocraft Laboratories, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: